BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 37067801)

  • 21. Response to Treatment, Racial and Ethnic Disparity, and Survival in Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy in the US.
    Shubeck S; Zhao F; Howard FM; Olopade OI; Huo D
    JAMA Netw Open; 2023 Mar; 6(3):e235834. PubMed ID: 36995711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of Racial Disparity in Survival Outcomes for Early Hormone Receptor-Positive Breast Cancer After Adjusting for Insurance Status and Neighborhood Deprivation: A Post Hoc Analysis of a Randomized Clinical Trial.
    Sadigh G; Gray RJ; Sparano JA; Yanez B; Garcia SF; Timsina LR; Obeng-Gyasi S; Gareen I; Sledge GW; Whelan TJ; Cella D; Wagner LI; Carlos RC
    JAMA Oncol; 2022 Apr; 8(4):579-586. PubMed ID: 35175284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Insurance Status and Racial Disparities With the Detection of Early-Stage Breast Cancer.
    Ko NY; Hong S; Winn RA; Calip GS
    JAMA Oncol; 2020 Mar; 6(3):385-392. PubMed ID: 31917398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Age, Body Mass Index, Tumor Subtype, and Racial and Ethnic Disparities in Breast Cancer Survival.
    Lipsyc-Sharf M; Ballman KV; Campbell JD; Muss HB; Perez EA; Shulman LN; Carey LA; Partridge AH; Warner ET
    JAMA Netw Open; 2023 Oct; 6(10):e2339584. PubMed ID: 37878313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors That Contributed to Black-White Disparities in Survival Among Nonelderly Women With Breast Cancer Between 2004 and 2013.
    Jemal A; Robbins AS; Lin CC; Flanders WD; DeSantis CE; Ward EM; Freedman RA
    J Clin Oncol; 2018 Jan; 36(1):14-24. PubMed ID: 29035645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Racial/Ethnic Disparities Associated With Initial Hemodialysis Access.
    Zarkowsky DS; Arhuidese IJ; Hicks CW; Canner JK; Qazi U; Obeid T; Schneider E; Abularrage CJ; Freischlag JA; Malas MB
    JAMA Surg; 2015 Jun; 150(6):529-36. PubMed ID: 25923973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of Modifiable Risk Factors in Young Adulthood With Racial Disparity in Incident Type 2 Diabetes During Middle Adulthood.
    Bancks MP; Kershaw K; Carson AP; Gordon-Larsen P; Schreiner PJ; Carnethon MR
    JAMA; 2017 Dec; 318(24):2457-2465. PubMed ID: 29279935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hysterectomy-Corrected Uterine Corpus Cancer Incidence Trends and Differences in Relative Survival Reveal Racial Disparities and Rising Rates of Nonendometrioid Cancers.
    Clarke MA; Devesa SS; Harvey SV; Wentzensen N
    J Clin Oncol; 2019 Aug; 37(22):1895-1908. PubMed ID: 31116674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors Associated With Racial and Ethnic Disparities in Locally Advanced Rectal Cancer Outcomes.
    Shulman RM; Deng M; Handorf EA; Meyer JE; Lynch SM; Arora S
    JAMA Netw Open; 2024 Feb; 7(2):e240044. PubMed ID: 38421650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Black race independently predicts worse survival in uterine carcinosarcoma.
    Erickson BK; Doo DW; Zhang B; Huh WK; Leath CA
    Gynecol Oncol; 2014 May; 133(2):238-41. PubMed ID: 24613675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential Outcomes Among Survivors of Head and Neck Cancer Belonging to Racial and Ethnic Minority Groups.
    Taylor DB; Osazuwa-Peters OL; Okafor SI; Boakye EA; Kuziez D; Perera C; Simpson MC; Barnes JM; Bulbul MG; Cannon TY; Watts TL; Megwalu UC; Varvares MA; Osazuwa-Peters N
    JAMA Otolaryngol Head Neck Surg; 2022 Feb; 148(2):119-127. PubMed ID: 34940784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics Associated With Racial/Ethnic Disparities in COVID-19 Outcomes in an Academic Health Care System.
    Gu T; Mack JA; Salvatore M; Prabhu Sankar S; Valley TS; Singh K; Nallamothu BK; Kheterpal S; Lisabeth L; Fritsche LG; Mukherjee B
    JAMA Netw Open; 2020 Oct; 3(10):e2025197. PubMed ID: 33084902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histopathologic differences account for racial disparity in uterine cancer survival.
    Smotkin D; Nevadunsky NS; Harris K; Einstein MH; Yu Y; Goldberg GL
    Gynecol Oncol; 2012 Dec; 127(3):616-9. PubMed ID: 22940487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determinants of black/white differences in colon cancer survival.
    Mayberry RM; Coates RJ; Hill HA; Click LA; Chen VW; Austin DF; Redmond CK; Fenoglio-Preiser CM; Hunter CP; Haynes MA
    J Natl Cancer Inst; 1995 Nov; 87(22):1686-93. PubMed ID: 7473817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Racial disparities in outcomes for high-grade uterine cancer: A California cancer registry study.
    Baskovic M; Lichtensztajn DY; Nguyen T; Karam A; English DP
    Cancer Med; 2018 Sep; 7(9):4485-4495. PubMed ID: 30123978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes Among African American and Non-Hispanic White Men With Metastatic Castration-Resistant Prostate Cancer With First-Line Abiraterone.
    Marar M; Long Q; Mamtani R; Narayan V; Vapiwala N; Parikh RB
    JAMA Netw Open; 2022 Jan; 5(1):e2142093. PubMed ID: 34985518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Racial and ethnic disparities in discharge to rehabilitation following traumatic brain injury.
    Meagher AD; Beadles CA; Doorey J; Charles AG
    J Neurosurg; 2015 Mar; 122(3):595-601. PubMed ID: 25415069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variation in Breast Cancer Subtype Incidence and Distribution by Race/Ethnicity in the United States From 2010 to 2015.
    Kong X; Liu Z; Cheng R; Sun L; Huang S; Fang Y; Wang J
    JAMA Netw Open; 2020 Oct; 3(10):e2020303. PubMed ID: 33074325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insurance status and racial differences in uterine cancer survival: a study of patients in the National Cancer Database.
    Fedewa SA; Lerro C; Chase D; Ward EM
    Gynecol Oncol; 2011 Jul; 122(1):63-8. PubMed ID: 21463888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disease progression, survival, and molecular disparities in Black and White patients with endometrioid endometrial carcinoma in real-world registries and GOG/NRG oncology randomized phase III clinical trials.
    Kopelman ZA; Tian C; Tumas J; Phippen NT; Tarney CM; Hope ER; Winkler SS; Jokajtys S; Kucera CW; Chan JK; Richardson MT; Kapp DS; Hamilton CA; Leath CA; Jones NL; Rocconi RP; Farley JH; Secord AA; Cosgrove CM; Powell MA; Klopp A; Walker JL; Fleming GF; Bateman NW; Conrads TP; Maxwell GL; Darcy KM
    Gynecol Oncol; 2024 Apr; 183():103-114. PubMed ID: 38593674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.